| |
|
Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). |
| |
|
Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? |
| |
|
Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. |
| |
|
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk. |
| |
|
Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. |
| |
|
Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. |
| |
|
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. |
| |
|
Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years old. |
| |
|
Hormone-replacement therapy and cardiovascular diseases. |
| |
|
Role of lipid and lipoprotein profiles in risk assessment and therapy. |
| |
|
Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. |
| |
|
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. |
| |
|
Protective role of uncoupling protein 2 in atherosclerosis. |
| |
|
Interleukin-18 and the Risk of Coronary Heart Disease in European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). |
| |
|
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. |
| |
|
Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results? |
| |
|
Risk factors for cardiovascular disease in patients with periodontitis. |
| |
|
Depression as a risk factor for mortality after acute myocardial infarction*1. |
| |
|
Inflammatory Markers and Onset of Cardiovascular Events. Results From the Health ABC Study. |
| |
|
Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). |
| |
|
The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. |
| |
|
Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men. |
| |
|
Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. |
| |
|
Screening for early detection of cardiovascular disease in asymptomatic individuals. |
| |
|
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. |
| |
|
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. |
| |
|
Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Danesh, J., P. Whincup, et al. |
| |
|
Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. |
| |
|
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. |
| |
|
Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. |
| |
|
Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. |
| |
|
Neutrophil elastase in human atherosclerotic plaques: production by macrophages. |
| |
|
The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? |
| |
|
Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. |
| |
|
Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. |
| |
|
Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus. |
| |
|
Prevention of cardiovascular ischemic events: high-risk and secondary prevention. |
| |
|
Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. |
| |
|
Smoking and health outcomes after percutaneous coronary intervention. |
| |
|
Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. |
| |
|
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. |
| |
|
Arterial compliance adds to conventional risk factors for prediction of angiographic coronary artery disease. |
| |
|
Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. |
| |
|
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. |
| |
|
Vascular disease, hypertension, and prevention: "from endothelium to clinical events". |
| |
|
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. |
| |
|
Association of polymorphisms of the apolipoprotein(a) gene with lipoprotein(a) levels and myocardial infarction. |
| |
|
Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. |
| |
|
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. |
| |
|
Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. |
| |
|
Absence of association between infectious agents and endothelial function in healthy young men. |
| |
|
Relation of high lipoprotein(a) to other traditional atherosclerotic risk factors in patients with coronary heart disease. |
| |
|
Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. |
| |
|
Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). |
| |
|
Secondary prevention with folic acid: effects on clinical outcomes. |
| |
|
A practical approach to risk assessment to prevent coronary artery disease and its complications. |
| |
|
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. |
| |
|
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. |
| |
|
Coronary risk factors predicting early and late coronary deaths. |
| |
|
Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. |
| |
|
Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study. |
| |
|
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study. |
| |
|
Antioxidant vitamins for prevention of cardiovascular disease. |
| |
|
Usefulness of carotid intimal medial thickness and flow-mediated dilation in a preventive cardiovascular practice. |
| |
|
Sex hormone levels and risk of cardiovascular events in postmenopausal women. |
| |
|
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. |
| |
|
High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. |
| |
|
Chronic periodontitis, a significant relationship with acute myocardial infarction. |
| |
|
Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. |
| |
|
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. |
| |
|
Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy). |
| |
|
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. |
| |
|
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. |
| |
|
Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study). |
| |
|
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. |
| |
|
Carbohydrates, dietary glycaemic load and glycaemic index, and risk of acute myocardial infarction. |
| |
|
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). |
| |
|
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). |
| |
|
Ergometric score systems after myocardial infarction: prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction. |
| |
|
Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. |
| |
|
Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment. |
| |
|
Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease. |
| |
|
Valvular and thoracic aortic calcium as a marker of the extent and severity of angiographic coronary artery disease. |
| |
|
Diets and clinical coronary events: the truth is out there. |
| |
|
Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. |
| |
|
Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting. |
| |
|
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. |
| |
|
Risk factors for coronary calcification in older subjects. The Rotterdam Coronary Calcification Study. |
| |
| |
  |
